Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06813053 · ClinicalTrials.gov registry record · NA

A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer

A NA study of Breast Cancer, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
3
Study locations

NCT06813053 is a NA study of Breast Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 60 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06813053, a NA study of Breast Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

This is a study to assess the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population. Insights gained from patient feedback and the implementation process will be used to improve the information delivered in the decision aid itself and to plan for a larger scale trial to compare the decision aid to standard of care.

Conditions Studied

Interventions

  • OTHER Standard of Care (SOC)
  • OTHER Decision Aid (DA)

Study Locations (3)

Colorado

  • Universtiy of Colorado Hospital - Aurora
  • UCHealth Cherry Creek Medical Center - Denver
  • UCHealth Highlands Ranch Hospital - Highlands Ranch

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-07-21
Est. Completion 2027-03
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT06813053

The ClinicalTrials.gov registry entry for NCT06813053 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care (SOC) is the first listed.

NCT06813053 reports 3 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06813053 about?

NCT06813053 is a clinical study titled "A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer". This is a study to assess the feasibility and acceptability of a novel decision aid (DA) in a newly diagnosed, early-stage breast cancer population. Insights gained from patient feedback and the implementation process will be used to improve the information delivered in the decision aid itself and t...

What is the current status of trial NCT06813053?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-21. Estimated completion is 2027-03.

What conditions does trial NCT06813053 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT06813053?

The interventions under investigation include: Standard of Care (SOC) (OTHER), Decision Aid (DA) (OTHER).

Who is sponsoring clinical trial NCT06813053?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06813053 being conducted?

This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.